Yungang Lu Net Worth

Yungang Lu biography

Dr. Yungang Lu serves as Independent Director of the Company. Dr. Lu has been a member of our board of directors since March 19, 2012. Dr. Lu is a Managing Partner of Fort Hill Capital Limited (“Fort Hill”), an investment partnership focusing on the global equity market. Prior to Fort Hill, Dr. Lu has served as a Managing Director of Seres Asset Management Limited, a Hong Kong-based Asian investment specialist, from August 2009 to October 2016, and a Managing Director of APAC Capital Advisors Limited, an investment manager focusing on Greater China equities, from 2004 to July 2009. Dr. Lu also serves as a director of the listed company Global Cord Blood Corporation, a provider of cord blood storage services primarily in China. Dr. Lu was a research analyst with Credit Suisse First Boston (Hong Kong), a financial services company, from 1998 to 2004, where his last position was the head of China Research, and was a research analyst with JP Morgan Securities Asia, a financial services company, in Hong Kong from 1997 to 1998. Dr. Lu received a B.S. in Biology from Peking University, an M.S. in Biochemistry from Brigham Young University and a Ph.D. in Finance from the University of California, Los Angeles. Dr. Lu is a Class III director.

How old is Yungang Lu?

Yungang Lu is 56, he's been the Independent Director of China Biologic Products Inc since 2012. There are 3 older and 2 younger executives at China Biologic Products Inc. The oldest executive at China Biologic Products Holdings Inc is Xiaosheng Shao, 63, who is the Independent Director.

What's Yungang Lu's mailing address?

Yungang's mailing address filed with the SEC is C/O CBPO, 18F, JIALONG INT'L TOWER, 19 CHAOYANG PARK RD., BEIJING, F4, 100125.

Insiders trading at China Biologic Products Inc

Over the last 17 years, insiders at China Biologic Products Inc have traded over $4,633,340,868 worth of China Biologic Products Inc stock and bought 6,331,200 units worth $103,519,340 . The most active insiders traders include Pincus Private Equity X, L...., X Biologics Llc Warburg Pin... oraz X Biologics Llckaye Charles.... On average, China Biologic Products Inc executives and independent directors trade stock every 38 days with the average trade being worth of $126,850,084. The most recent stock trade was executed by Zhijing Cbpo Liu on 8 May 2017, trading 7,500 units of CBPO stock currently worth $73,875.

What does China Biologic Products Inc do?

China Biologic Products Inc executives and stock owners

China Biologic Products Inc executives and other stock owners filed with the SEC include:

• Ming Yang,
  Chief Financial Officer
• Xiaosheng Shao,
  Independent Director
• Qi Ning,
  Independent Director
• Yungang Lu,
  Independent Director
• Yue'e Zhang,
  Director
• Hui Li,
  Director
• Joseph Chow,
  Chairman of the Board, Chief Executive Officer
• Albert Yeung,
  Director
• Gang Cbpo Yang,
  Corporate Vice President
• Zhijun Tong,
  Director
• Min Fang,
  Director
• Zhijing Cbpo Liu,
  Corporate Vice President
• David Gao,
  Chief Executive Officer
• Wenfang Liu,
  Director
• X Biologics Llckaye Charles...,
  
• Sean Shao,
  Director
• X Biologics Llc Warburg Pin...,
  
• Ming Yin,
  Senior Corporate VP
• Le Zhang,
  Director
• Bing Li,
  Director
• X Biologics Llc Warburg Pin...,
  
• Pincus Private Equity X, L....,
  
• Lin Ling Li,
  Director
• Chao Ming Zhao,
  Chief Financial Officer
• Ling Siu Chan,
  Director
• Yuyun Tristan Kuo,
  Chief Financial Officer
• Barry M Kitt,
  10% owner
• Tong Jun Lin,
  Director
• Xiangmin Cui,
  Director
• Pincus Private Equity X, L....,
  
• Cbpo Stanley Wong,
  Chief Executive Officer